Randomized Trial of High Dose Tirilzad in Acute Stroke "RANTTAS II"

Completed

Phase 3 Results

Summary of Purpose

To test the hypothesis that the lack of efficacy of tirlazad mesylate demonstrated by RANTASS was secondary to inadequate dose, especially in females.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Pharamacia-Upjohn, Inc., Kalamazoo, MI

Trial Design

Randomized, controlled, multicenter study involving 126 patients.

Contacts

  • E. Clarke Haley, Jr, MD, Department of Neurology, Box 394, University of Virginia Health Sciences Center, Charlottesville, VA 22908.

    ech@virginia.edu